Natural History and Prospective Cohort Study to Describe the Neurological, Neurodevelopmental and other Clinical Outcomes in Children after Zika Virus Infection (2017)
NIH, $3500000
Evaluation of Moderate to Severe Influenza Disease in Children 6 months to 8 years in Colorado (2017)
GSK, $500000
Research interests for Patients:
Vaccine safety
New vaccine global introductions and epidemiology
Dengue and Zika infections
Pneumococcal disease and prevention
Information for Referring Providers
Clinical Interests for Referring Providers
Tropical infectious diseases
Vaccine adverse events
Meningitis and encephalitis
Research Interest for Referring Providers
Vaccine safety
New vaccine global introductions and epidemiology
Dengue and Zika infections
Pneumococcal disease and prevention
Clinic Phone:(720) 777-6981 Fax Phone:(720) 777-7295